Nmnat2 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Nmnat2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@sasaki2016]
NMNAT2 (NMN Adenylyltransferase 2) is a critical enzyme in neuronal NAD+ biosynthesis that maintains axonal integrity and protects against Wallerian degeneration. [@wan2018]
Protein Overview
Structure
Domain Architecture:
N-terminal Domain: Variable region involved in axonal targeting
Adenylyltransferase Domain: Central catalytic domain (~350 aa) that binds NMN and ATP
C-terminal Region: Regulatory region affecting protein stability
Structural Features:
The catalytic domain adopts a Rossmann-like fold typical of nucleotidyltransferases
Dimerization is required for enzymatic activity
The protein forms homodimers in solution
Normal Function
Enzymatic Activity:
Catalyzes the ATP-dependent conversion of NMN to NAD+
Uses ATP as an adenylate donor
Km for NMN: ~10 μM; Km for ATP: ~100 μM
Neuronal Functions:
NAD+ Maintenance: Primary source of neuronal NAD+ in axons
Axonal Energy Metabolism: NAD+ serves as essential cofactor for glycolytic and mitochondrial enzymes
Signaling: NAD+ is substrate for sirtuins, PARPs, and CD38/157 ectoenzymes
Axonal Protection: NMNAT2 protein levels determine whether axons survive or degenerate after injury
SARM1 Interaction:
NMNAT2 is a key substrate for SARM1's NADase activity
SARM1 activation leads to rapid NMNAT2 degradation
NAD+ depletion triggers axonal energy crisis and degeneration
Role in Disease
Wallerian Degeneration:
NMNAT2 levels decline after axotomy due to lack of somatic support
Declining NMNAT2 leads to NAD+ depletion via SARM1
The "Wallerian degeneration" phenotype (slow degeneration) is NMNAT2-dependent
WLD^S mice overexpress NMNAT2 and show axon protection
Alzheimer's Disease:
NAD+ levels decline in AD brain
Impaired NMNAT2 function may contribute to synaptic loss
NAD+ supplementation approaches are being explored
Parkinson's Disease:
Dopaminergic [neurons](/entities/neurons) require high energy output
NMNAT2 dysfunction may contribute to axonal vulnerability
SARM1-mediated degeneration may play a role
Charcot-Marie-Tooth Disease:
Rare NMNAT2 variants cause axonal CMT2
Affected individuals present with distal muscle weakness and sensory loss
Therapeutic Targeting
NAD+ Boosters:
SARM1 Inhibitors:
Small molecule SARM1 inhibitors in development
Goal: Prevent NMNAT2 degradation and NAD+ depletion
Potential for treating peripheral neuropathies and traumatic nerve injury
Gene Therapy:
AAV-mediated NMNAT2 overexpression approaches
Targeting peripheral nervous system first
Overview
Nmnat2 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Nmnat2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
[Related Topics](/index)
External Links
References
[Gilley J, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/26189314/)
[Sasaki Y, et al, (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27984726/)
[Wan L, et al, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29305389/)
[Essuman K, et al, (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28279355/)
[Yamamoto M, et al, (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/30624682/)